Affordable Access

Selective elimination of leukemic CD34(+) progenitor cells by cytotoxic T lymphocytes specific for WT1.

Authors
  • Gao, L
  • Bellantuono, I
  • Elsässer, A
  • Marley, S B
  • Gordon, M Y
  • Goldman, J M
  • Stauss, H J
Type
Published Article
Journal
Blood
Publication Date
Apr 01, 2000
Volume
95
Issue
7
Pages
2198–2203
Identifiers
PMID: 10733485
Source
Medline
License
Unknown

Abstract

Hematologic malignancies such as acute and chronic myeloid leukemia are characterized by the malignant transformation of immature CD34(+) progenitor cells. Transformation is associated with elevated expression of the Wilm's tumor gene encoded transcription factor (WT1). Here we demonstrate that WT1 can serve as a target for cytotoxic T lymphocytes (CTL) with exquisite specificity for leukemic progenitor cells. HLA-A0201- restricted CTL specific for WT1 kill leukemia cell lines and inhibit colony formation by transformed CD34(+) progenitor cells isolated from patients with chronic myeloid leukemia (CML), whereas colony formation by normal CD34(+) progenitor cells is unaffected. Thus, the tissue-specific transcription factor WT1 is an ideal target for CTL-mediated purging of leukemic progenitor cells in vitro and for antigen-specific therapy of leukemia and other WT1-expressing malignancies in vivo.

Report this publication

Statistics

Seen <100 times